{
  "abstract": "Background: The use of P2Y12 inhibitor is highly variable, and administration is frequently confounded by inconsistent documentation that heightens risks for mismanagement, particularly following transitions of care.\n\nProject Rationale: Insufficient documentation clearly defining the indication and therapeutic duration for antiplatelet agents carries potential risks for bleeding and/or ischemia. This was observed in patients who were veterans and was felt to represent a modifiable quality gap.\n\nProject Summary: A 2-phase quality improvement initiative at the New Mexico Veterans Affairs Health Care System reviewed documentation among 1,100 veterans prescribed a P2Y12 inhibitor. In a randomly selected sample of 135 patients, 27% lacked documentation clearly defining therapeutic duration, and 8.4% continued P2Y12 inhibitor beyond the intended stop date. A structured electronic health record document and automated reminders were developed using a Plan-Do-Study-Act framework to address these concerns.\n\nTake-Home Message: Structured electronic health record documentation with automated reminders can improve antiplatelet stewardship and safety.",
  "abstract_shown": true,
  "affiliations": [
    "Department of Internal Medicine, University of New Mexico, Albuquerque, New Mexico, USA",
    "Division of Cardiology, Department of Internal Medicine, University of New Mexico, Albuquerque, New Mexico, USA",
    "Department of Neurology, University of New Mexico, Albuquerque, New Mexico, USA"
  ],
  "article_type": "case report",
  "arxiv": null,
  "author_total": 6,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Rudra Pratap Singh"
    },
    {
      "affs": [
        1
      ],
      "name": "Breandan Kelly"
    },
    {
      "affs": [
        2
      ],
      "name": "Seerat Sachdeva"
    },
    {
      "affs": [
        0
      ],
      "name": "Stephanie Rosenberg"
    },
    {
      "affs": [
        1
      ],
      "name": "Harmon R. Cannon"
    },
    {
      "affs": [
        0
      ],
      "name": "Linda Macdonald"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/4zbsh0t5zr8k8.bib",
  "cited_by": 0,
  "doi": "10.1016/j.jaccas.2026.109457",
  "fulltext_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC13728360/",
  "id": "4zbsh0t5zr8k8",
  "issns": [
    "2666-0849"
  ],
  "landing_url": "https://doi.org/10.1016/j.jaccas.2026.109457",
  "language": "en",
  "licence": "CC-BY-NC-ND-4.0",
  "licence_label": "CC BY-NC-ND 4.0",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by-nc-nd/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "heading",
      "Outcomes and Quality"
    ],
    [
      "heading",
      "Quality Improvement Projects"
    ],
    [
      "openalex",
      "3605|Electronic Health Records Systems"
    ]
  ],
  "openalex": "W7213393463",
  "pdf_url": null,
  "pmcid": "PMC13728360",
  "pmid": "42752045",
  "published": "2026-09-16",
  "publisher": "Elsevier",
  "ris": "https://research.draconitic.com/paper/4zbsh0t5zr8k8.ris",
  "sources": [
    {
      "first_seen": "2026-11-07T12:21:22Z",
      "native_id": "PMC13728360",
      "source": "pmc",
      "url": "https://doi.org/10.1016/j.jaccas.2026.109457"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "journal-openalex:2705|Cardiac Valve Diseases and Treatments",
      "subfield": "cardiovascular"
    }
  ],
  "title": "Tailoring Antiplatelet Adherence",
  "title_text": "Tailoring Antiplatelet Adherence",
  "type": "peer-reviewed",
  "updated_at": "2026-11-07T12:21:22Z",
  "url": "https://research.draconitic.com/paper/4zbsh0t5zr8k8",
  "venue": "JACC Case Reports",
  "versions": []
}